ResearcherUniversity of KansasNo recent work listed

Ian M. Freed

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4909-3549; OpenAlex author ID A5079611127. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2023: 1 paper

Papers 1

Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients. Co-author DOI 10.3390/cells12182266 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Weijing Sun · 1 shared paper, 2023 · strength 0.15
- Paper Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients. DOI 10.3390/cells12182266 ↗
Steven A. Soper · 1 shared paper, 2023 · strength 0.15
- Paper Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients. DOI 10.3390/cells12182266 ↗
Anup Kasi · 1 shared paper, 2023 · strength 0.15
- Paper Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients. DOI 10.3390/cells12182266 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.